AI-generated summary
The authors studied 71 patients with recurrent herpes labialis over 16 months, comparing laser phototherapy at 780 nm with topical aciclovir. They report that the laser group had significantly smaller lesions and less inflammatory edema, while changes in pain and monthly recurrences were not statistically significant.
- Participants
- 71
- Who or what was studied
- Patients with recurrent herpes labialis (HSV-1 labial infection), divided into an experimental laser group (n = 41) and a topical aciclovir control group (n = 30).
- Wavelengths
- 780 nm
- Limits stated in the abstract
- The abstract does not state how the groups were allocated or blinded, and pain and recurrence differences did not reach statistical significance.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 780 nm
- Power
- 60 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Phototherapy, Laser, Statistical significance, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.